Kari L. Struemph, Ph.D.
Dr. Struemph joined the Health Psychology and Neurobehavioral Research Team as a CRTA (Cancer Research Training Award) Fellow funded by a grant from the Neurofibromatosis Therapeutic Accelerations Program (NTAP). As a research fellow, Dr. Struemph is managing the group’s current research project to validate disease-specific pain and pain interference patient-reported outcome scales to be used in clinical trials with individuals with neurofibromatosis type 1 (NF1). This is a multi-site study, collaborating with researchers at Children’s National Medical Center, Cincinnati Children’s Hospital, and University of Chicago Medical Center.
As a postdoctoral fellow, Dr. Struemph is integrally involved in a POB research protocol focused on the modification and evaluation of patient reported outcomes (PROs) for individuals diagnosed with neurofibromatosis type 1 (NF1). The project, funded by the Neurofibromatosis Therapeutic Acceleration Program (NTAP), aims to develop disease-specific measures of pain and how that pain interferes with the daily lives of individuals diagnosed with NF1. The protocol was accepted into the U.S. Food and Drug Administration (FDA) Drug Development Tool Qualification Program on the path to establishing FDA-approved primary outcome measures that would be able to support labeling claims. Dr. Struemph also provides support for other select study protocols within the POB and other NCI branches.
- Health Psychol. 33(8): 783-791, 2014. [ Journal Article ]
- Circulation. 130(20): e175-e176, 2014. [ Journal Article ]
Monitoring developmental risk and promoting success for children with congenital heart disease: Recommendations for cardiac neurodevelopmental follow-up programs.Clin Pract Pediatr Psychol. 2(2): 153-165, 2014. [ Journal Article ]
Neuropsychological sequelae of diabetes.In: Handbook of Medical Neuropsychology. New York: Springer-Verlag 2010. [ Book Chapter ]
Kari Struemph, Ph.D., a licensed psychologist in the state of Maryland, joined the Health Psychology and Neurobehavioral Research Program in the Pediatric Oncology Branch (POB) of the National Cancer Institute (NCI) in 2014, on a Cancer Research Training Award (CRTA) funded by the Neurofibromatosis Therapeutic Acceleration Program (NTAP).
Dr. Struemph is originally from Topeka, Kansas and received her Bachelor of Arts degree from the University of Kansas in 2004. She moved to Richmond, Virginia in 2006 joining the Clinical Child Doctoral Program at Virginia Commonwealth University (VCU). She graduated from VCU in 2012 with a Ph.D. in Clinical Child Psychology, with special focii in Pediatric and Health Psychology. She completed a competitive internship and fellowship in pediatric psychology at the Nemours/Alfred I duPont Hospital for Children in Wilmingon, Delaware. On fellowship Dr. Struemph specialized in providing services to children, adolescents, and young adults in the Divisions of Cardiology, Oncology, and Nephrology. During her time at AI duPont, she fostered and expanded a relationship between the Division of Behavioral Health and the blood and bone marrow transplant program and established a new consultation/liaison relationship with the kidney transplant program. Her clinical experience and interests are focused in the areas of adjustment to medical illness, adherence to difficult medical regimens, and providing support to parents of children diagnosed with a chronic illness